Transcending tradition: Quality of life as the inextricable link between activities of daily living and specific organ and disease states

Research in Human Capital and Development

Volumn 16, Issue , 2008, Pages 29-52

  Vinik, Etta J ^a   Vinik, Aaron I ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

EID: 53849125437     PISSN: 01943960     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0194-3960(08)16002-4     Document Type: Review

References (44)

1. Andrews F.M., and Withey S.B. Developing measures of perceived life quality: Results from several national surveys. Social Indicators Research 1 (1974) 1-26
2. Bastyr, E. J. III, Price, K. L., Bril, V., & MBBQ Study Group. (2005). Development and validity testing of the neuropathy total symptom score-6: Questionnaire for the study of sensory symptoms of diabetic peripheral neuropathy. Clinical Therapeutics, 27(8) 1278-1294.
3. Berzon R.A. Understanding and using health-related quality of life instruments within clinical research studies. In: Stauqet M.J., Hays R.D., and Fayers P.M. (Eds). Quality of life assessment in clinical trials, methods and practice (1998), Oxford University Press, New York 3-15
4. Boulton A.J., Vinik A.I., Arezzo J.C., Bril V., Feldman E.L., Freeman R., Malik R.A., Maser R.E., Sosenko J.M., and Ziegler D. Diabetic neuropathies: A statement by the American diabetes association. Diabetes Care 28 4 (2005) 956-962
5. Brislin R.W., Lonner W.J., and Thorndike R.M. Cross-cultural research methods (1973), Wiley and Sons, New York
6. Bullinger M., Anderson R., Cella D., and Aaronson N. Developing and evaluating cross-cultural instruments from minimum requirements to optimal models. Quality of Life Research: An International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation 2 (1993) 451-459
7. Calman K.C. Quality of life in cancer patients - An hypothesis. Journal of Medical Ethics 10 (1984) 124-127
8. Cella D.F., Wiklund I., Shumaker S.A., and Aaronson N.K. Integrating health-related quality of life into cross-national clinical trials. Quality of Life Research: An International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation 2 6 (1993) 433-440
9. Donofrio P., Raskin P., Rosenthal N., Hewitt D., Jordan D., Xiang J., and Vinik A. For the CAPSS-141 Study Group: Safety and effectiveness of topiramate for the management of painful diabetic peripheral neuropathy in an open-label extension study (Abstract). Clinical Therapeutics 27 (2005) 1420-1431
10. Dyck P.J. Detection, characterization, and staging of polyneuropathy: Assessed in diabetes. Muscle Nerve 11 (1988) 21-32
11. Elkington J.P. Medicine and quality of life. Annals of Internal Medicine 64 (1966) 711-714 (editorial)
12. Fallowfield L. Quality of quality-of-life data. Lancet 348 (1996) 421-422
13. Goldstein D.J., Lu Y., Detke M.J., Lee T.C., and Iyengar S. Duloxetine vs. placebo in patients with painful diabetic neuropathy. Pain 116 1-2 (2005) 109-118
14. Gough I.R., Furnival C.M., Schilder L., and Grove W. Assessment of the quality of life of patients with advanced cancer. European Journal of Cancer and Clinical Oncology 19 8 (1983) 1161-1165
15. Grootenhuis P.A., Snoek F.J., Heine R.J., and Bouter L.M. Development of a type 2 diabetes symptom checklist: a measure of symptom severity. Diabetic Medicine 11 (1994) 253-261
16. Guyatt G., Feeny D., and Patrick D. Issues in quality of life measurement in clinical trials. Controlled Clinical Trials 12 (1991) 81S-90S
17. Guyatt G.H., Bombardier C., and Tugwell P.X. Measuring disease-specific quality of life in clinical trials. Canadian Medical Association Journal 134 April (1986) 889-895
18. Hayes, R. D., Anderson, R., & Revicki, D. A. (1995). Psychometric evaluation and interpretation of health-related quality of life data. In: The international assessment of health-related quality of life: Theory, translation, measurement and analysis (pp. 103-114). Oxford: Rapid Communications of Oxford, Ltd.
19. Hunt S. Cross-cultural issues in the use of socio-medical indicators. Health Policy 6 (1986) 149-158
20. Kaplan R.M., and Bush J.W. Health-related quality of life measurements for evaluation, research and policy analysis. Health Psychology 1 (1982) 61-80
21. Leadbetter, R. (2000). Asclepius. Encyclopedia Mythica. Available at: http://www.pantheon.org/articles/a/asclepius.html. Accessed January 31, 2006.
22. Medical Outcomes Trust Foundation. (1994). A not-for-profit organization incorporated in Massachusetts, began its program in 1994 to improve health and promote the science of outcomes measurement.
23. Pigou A.C. The economics of welfare (1920), Macmillan and Co, London
24. Polonsky W.H. Understanding and assessing diabetes-specific quality of life. Diabetes Spectrum 13 1 (2000) 36-41
25. Raskin P., Donofrio P.D., Rosenthal N.R., Hewitt D.J., Jordan D.M., Xiang J., and Vinik A.I. Topiramate vs placebo in painful diabetic neuropathy: Analgesic and metabolic effects. Neurology 63 (2004) 865-873
26. Resnick H.E., Vinik A.I., Schwartz A.V., Leveille S.G., Brancati F.L., Balfour J., and Guralnik J.M. Independent effects of peripheral nerve dysfunction on lower-extremity physical function in old age: The Women's Health and Aging Study. Diabetes Care 23 11 (2000) 1642-1647
27. Rice A.L., Vinik E.J., Barlow P.M., Ford-Molvik S.L., and Vinik A.L. Topiramate improves QOL in patients with diabetic neuropathies, correlating with improved nerve function. Inpharma Weekly 18 (2006) 1544
28. Ruta D.A., and Garratt A.M. Health status to quality of life measurement. In: Jenkinson C. (Ed). Measuring health and medical outcomes (1995), UCL Press, London 138-159
29. Schuessler K.F., and Fisher G.A. Quality of life research on sociology. Annual Review of Sociology 11 (1985) 129-149
30. Shumaker, S. A., & Naughton, M. J. (1995). The International assessment of health-related quality of life: A theoretical perspective (pp. 3-10). Oxford: Rapid Communications of Oxford, Ltd.
31. Testa M.A. Quality of life assessment in diabetes research: Interpreting the magnitude and meaning of treatment effects. Diabetes Spectrum 13 1 (2002) 29-35
32. Thienel U., Neto W., Schwabe S.K., and Vijapurkar U. Topiramate in painful diabetic polyneuropathy: Findings from three double-blind placebo-controlled trials. Acta Neurologica Scandinavica 110 4 (2004) 221-231
33. Vileikyte L., Leventhal H., Gonzalez J.S., Peyrot M., Rubin R.R., Ulbrecht J.S., Garrow A., Waterman C., Cavanagh P.R., and Boulton A.J. Diabetic peripheral neuropathy and depressive symptoms: the association revisited. Diabetes Care 28 10 October (2005) 2378-2383
34. Vileikyte L., Peyrot M., Bundy C., Rubin R.R., Leventhal H., Mora P., Shaw J.E., Baker P., and Boulton A.J. The development and validation of a neuropathy- and foot ulcer-specific quality of life instrument. Diabetes Care 26 (2003) 2549-2555
35. Vinik A.I. Diabetic neuropathies: Evaluation, management and controversies in treatment options. In: LeRoith D. (Ed). Controversies in treating diabetes, clinical and research aspects (2007), Humana Press, Totowa, NJ 135-156
36. Vinik A.I., and Mehrabyan A. Diabetic neuropathies. The Medical Clinics of North America 88 4 (2004) 947-999
37. Vinik E., Paulson J., Ford-Molvik S., Oglesby A., Watkins J., Hayes C., and Vinik A. Validation of the German translation of the Norfolk QOL-DN, nerve fiber specific questionnaire in a national, multicenter cost of illness study (DIMICO) for diabetic microvascular complications in Germany (Abstract). ISPOR 10th Annual International Meeting. Value in Health 8 3 (2005) 364-365
38. Vinik E., Stansberry K., and Vinik A. Neuropathy quality of life tool (Norfolk QOL-DN) in a large clinical trial: Comparison with symptom scores (NSS), nerve impairment (NISS), quantitative sensory (QST), autonomic (QAFT) tests and electrophysiology (Late Breaking Abstract). Diabetes 52 Suppl 1 (2003) A198
39. Vinik E.J., Hayes C., Oglesby A., and Vinik A.I. Identification of factors in the nerve fiber specific quality of life (QOL-DN) inventory that reflect QOL and health status (Abstract). Diabetes 53 (2004) A295
40. Vinik E.J., Hayes R.P., Oglesby A., Bastyr E., Barlow P., Ford-Molvik S.L., and Vinik A.I. The development and validation of the Norfolk QOL-DN, a new measure of patients' perception of the effects of diabetes and diabetic neuropathy. Diabetes Technology & Therapeutics 7 3 (2005) 497-508
41. Vinik E.J., Stansberry K.B., Zarrabi L., Witherspoon C.A.G., McNitt P.M., and Vinik A.I. Development of a sensitive, specific quality of life inventory for peripheral neuropathy (Abstract). Diabetes 49 (2000) A819
42. Ware Jr. J.E., and Sherbourne C.D. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Medical Care 30 (1992) 473-483
43. Witzke K.A., and Vinik A.I. Diabetic neuropathy in older adults. Reviews in Endocrine and Metabolic Disorders 6 2 (2005) 117-127
44. Wood-Dauphinee S. Assessing quality of life in clinical research: From where have we come and where are we going?. Journal of Clinical Epidemiology 52 (1999) 355-363